Communiqués Korro Bio, Inc.

Actions

KRRO

US5009461089

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 06/06/2024			Varia. 5j.	Varia. 1 janv.
44,74 ^USD	-5,31 %		-10,50 %	-6,66 %

15/05	KORRO BIO, INC. : HC Wainwright toujours positif	ZM
14/05	Korro Bio réduit sa perte nette au 1er trimestre ; Kemi Olugemo est nommé directeur médical	MT

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Korro to Participate in Upcoming June Investor and Scientific Conferences	30/05	AQ
Korro Bio : May 2024 Corporate Presentation	20/05	PU
Korro Presents Additional Preclinical Data for KRRO-110 at the American Thoracic Society 2024 International Conference	20/05	AQ
Korro Bio : Q1’24 Corporate Presentation	14/05	PU
Korro Reports First Quarter 2024 Financial Results and Appointment of Kemi Olugemo, M.D. as Chief Medical Officer	14/05	AQ
Korro Announces $70 Million Private Placement	18/04	AQ
Korro to Participate in Upcoming Investor Conferences	01/04	AQ
Korro Reports Full Year 2023 Financial Results and Highlights Recent Progress	26/03	AQ
Korro Bio: Development and Application of Graph Neural Networks to Design Guide Oligonucleotides that Promote RNA Editing	13/03	PU
Korro to Present at the TD Cowen 44th Annual Health Care Conference	27/02	AQ
Korro Bio Highlights Data for its Lead Program in Alpha-1 Antitrypsin Deficiency (AATD) and Progress Across its RNA Editing Portfolio	18/01	AQ
Korro to Present at the 42nd Annual J.P. Morgan Healthcare Conference	04/01	AQ
FREQUENCY THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Frequency Therapeutics, Inc. - FREQ	06/10/23	BU
Frequency Therapeutics : Termination of Material Agreement - Form 8-K	27/09/23	PU
Frequency Therapeutics Provides Business Updates and Second Quarter 2023 Financial Results	10/08/23	BU
FREQUENCY THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Frequency Therapeutics, Inc. - FREQ	21/07/23	BU
Korro Bio and Frequency Therapeutics Announce Merger Agreement	17/07/23	AQ
FREQ Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Frequency Therapeutics, Inc. Is Fair to Shareholders	14/07/23	BU
Korro Bio and Frequency Therapeutics Announce Merger Agreement	14/07/23	BU
Frequency Therapeutics : Costs Associated with Exit/Disposal - Form 8-K	06/06/23	PU

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Korro Bio, Inc.

Actions

KRRO

US5009461089

Communiqués

Filtres